80 related articles for article (PubMed ID: 1418269)
1. Effect of storage time of pleural effusions on immunocytochemical cell surface analysis of tumor cells.
Guzman J; Arbogast S; Bross KJ; Finke R; Costabel U
Anal Quant Cytol Histol; 1992 Jun; 14(3):203-9. PubMed ID: 1418269
[TBL] [Abstract][Full Text] [Related]
2. Effect of storage time on the analysis of lymphocyte subpopulations in pleural effusions.
Guzman J; Arbogast S; Bross KJ; Finke R; Costabel U
Acta Cytol; 1993; 37(3):267-71. PubMed ID: 7684547
[TBL] [Abstract][Full Text] [Related]
3. Malignant pleural effusions due to small cell carcinoma of the lung. An immunocytochemical cell-surface analysis of lymphocytes and tumor cells.
Guzman J; Bross KJ; Costabel U
Acta Cytol; 1990; 34(4):497-501. PubMed ID: 2165344
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
[TBL] [Abstract][Full Text] [Related]
5. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
Shaw P; Buckman R; Law J; Baumal R; Marks A
Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
[TBL] [Abstract][Full Text] [Related]
7. [Immunocytochemical characterization of malignant pleural effusions of small cell bronchial cancer].
Guzman J; Kraft A; Bross KJ; Würtemberger G; Costabel U
Pneumologie; 1990 Feb; 44 Suppl 1():601-2. PubMed ID: 2164207
[TBL] [Abstract][Full Text] [Related]
8. [Use of immunohistochemistry in clinical cytology].
Weintraub D; Weintraub J; Vassilakos P
Ann Pathol; 1987; 7(1):25-30. PubMed ID: 3304314
[TBL] [Abstract][Full Text] [Related]
9. [Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion].
Hiratani K; Hirota M; Fukushima K; Tomonaga A; Saito A; Hara K; Fujiwara K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2678-80. PubMed ID: 3017233
[No Abstract] [Full Text] [Related]
10. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
Paluch E; Ioachim HL
J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
[TBL] [Abstract][Full Text] [Related]
11. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a lung-cancer-associated auto-antigen.
Zeng CQ; Alpert LC; Alpert E
Int J Cancer; 1992 Oct; 52(4):523-9. PubMed ID: 1399130
[TBL] [Abstract][Full Text] [Related]
13. Proceedings: Membrane-related antigens in pleural fluids of patients with breast cancer.
Gorsky Y; Sulitzeanu D
Isr J Med Sci; 1975 Dec; 11(12):1399-1400. PubMed ID: 1218999
[No Abstract] [Full Text] [Related]
14. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
15. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
Pettersson T; Welin MG; Weber TH
J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
[TBL] [Abstract][Full Text] [Related]
16. Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.
Prado-Garcia H; Romero-Garcia S; Rumbo-Nava U; Lopez-Gonzalez JS
Anticancer Res; 2015 Mar; 35(3):1529-35. PubMed ID: 25750307
[TBL] [Abstract][Full Text] [Related]
17. Identification of a tumor-related protein antigen in immune complexes derived from pleural effusions of patients with bronchial carcinoma.
Lawniczak M; Jezewska E; Górny MK; Zeromski J
Neoplasma; 1985; 32(1):9-20. PubMed ID: 3982564
[TBL] [Abstract][Full Text] [Related]
18. Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.
Prado-Garcia H; Romero-Garcia S; Morales-Fuentes J; Aguilar-Cazares D; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2012 Jul; 61(7):1065-80. PubMed ID: 22159518
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
Tamiolakis D; Papadopoulos N; Cheva A; Lambropoulou M; Kotini A; Mikroulis D; Didilis V; Bitzikas N; Bougioukas G
Minerva Med; 2002 Dec; 93(6):479-83. PubMed ID: 12515971
[TBL] [Abstract][Full Text] [Related]
20. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
